Literature DB >> 1347219

Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease.

H Yoshino1, Y Nakagawa-Hattori, T Kondo, Y Mizuno.   

Abstract

Mitochondrial Complex I deficiencies have been described not only in the brain but also in the skeletal muscle and platelets in Parkinson's disease (PD). We report activities of Complex I, II, III, and IV in lymphocytes and platelets in 20 patients with PD and age-matched controls. A small but a significant decrease in the platelet Complex I activity was found in PD (9.14 +/- 1.86 units/mg protein) compared with that in the control (12.37 +/- 2.66 units/mg protein) (P = 0.0002). The lymphocyte Complex I activity was about the same between PD and the control. The activity of Complex II was slightly diminished in both platelets and lymphocytes in PD. Rather small decrease in the platelet Complex I activity in PD may be clinically non-significant. But it may indicate the presence of a qualitatively similar abnormality in platelets as in the nigro-striatal neurons. The cause for decrease in the Complex II activity is unknown at this moment. Further studies seem necessary.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347219     DOI: 10.1007/bf02257619

Source DB:  PubMed          Journal:  J Neural Transm Park Dis Dement Sect        ISSN: 0936-3076


  52 in total

Review 1.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

2.  Complex I deficiency in Parkinson's disease frontal cortex.

Authors:  W Davis Parker; Janice K Parks; Russell H Swerdlow
Journal:  Brain Res       Date:  2007-11-01       Impact factor: 3.252

Review 3.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

Review 4.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

5.  Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease.

Authors:  Alexandra Isabel Rosa; Sara Duarte-Silva; Anabela Silva-Fernandes; Maria João Nunes; Andreia Neves Carvalho; Elsa Rodrigues; Maria João Gama; Cecília Maria Pereira Rodrigues; Patrícia Maciel; Margarida Castro-Caldas
Journal:  Mol Neurobiol       Date:  2018-04-12       Impact factor: 5.590

6.  Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease.

Authors:  Jeff M Bronstein; Kimberly Paul; Laurice Yang; Richard H Haas; Clifford W Shults; Thuy Le; Beate Ritz
Journal:  Mov Disord       Date:  2015-03-11       Impact factor: 10.338

Review 7.  Mitochondrial mechanisms of redox cycling agents implicated in Parkinson's disease.

Authors:  Pamela Lopert; Manisha Patel
Journal:  J Neural Transm (Vienna)       Date:  2015-03-07       Impact factor: 3.575

8.  Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals--and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers.

Authors:  A Chomyn; S T Lai; R Shakeley; N Bresolin; G Scarlato; G Attardi
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

Review 9.  Chipping away at diagnostics for neurodegenerative diseases.

Authors:  Clemens R Scherzer
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

10.  Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress.

Authors:  Clement A Gautier; Tohru Kitada; Jie Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.